Copyright © 2012 Julian J. Raffoul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. R. Siegal, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar
2. M. R. Kelley, DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications, Academic Press, New York, NY, USA, 2012.
3. E. L. Goode, C. M. Ulrich, and J. D. Potter, “Polymorphisms in DNA repair genes and associations with cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 12, pp. 1513–1530, 2002. View at Scopus
4. J. G. de Boer, “Polymorphisms in DNA repair and environmental interactions,” Mutation Research, vol. 509, no. 1-2, pp. 201–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
5. H. W. Mohrenweiser, D. M. Wilson III, and I. M. Jones, “Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes,” Mutation Research, vol. 526, no. 1-2, pp. 93–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
6. I. M. Jones, C. B. Thomas, T. Xi, D. O. Nelson, and H. W. Mohrenweiser, “The genetic basis for variation in radiation sensitivity in the general population,” Radiation Research, vol. 163, no. 6, pp. 700–701, 2005. View at Scopus
7. G. L. Blackburn, V. L. W. Go, J. Milner, and D. Heber, Nutritional Oncology, Academic Press, New York, NY, USA, 2nd edition, 2006.
8. A. R. Amin, O. Kucuk, F. R. Khuri, and D. M. Shin, “Perspectives for cancer prevention with natural compounds,” Journal of Clinical Oncology, vol. 27, no. 16, pp. 2712–2725, 2009. View at Publisher · View at Google Scholar · View at Scopus
9. N. P. Gullett, A. R. Ruhul Amin, S. Bayraktar et al., “Cancer prevention with natural compounds,” Seminars in Oncology, vol. 37, no. 3, pp. 258–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
10. M. Goodman, R. M. Bostick, O. Kucuk, and D. P. Jones, “Clinical trials of antioxidants as cancer prevention agents: past, present, and future,” Free Radical Biology and Medicine, vol. 51, no. 5, pp. 1068–1084, 2011. View at Publisher · View at Google Scholar · View at Scopus
11. J. J. Raffoul, F. H. Sarkar, and G. G. Hillman, “Radiosensitization of prostate cancer by soy isoflavones,” Current Cancer Drug Targets, vol. 7, no. 8, pp. 759–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
12. G. G. Hillman and V. Singh-Gupta, “Soy isoflavones sensitize cancer cells to radiotherapy,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 289–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
13. F. H. Sarkar and Y. Li, “Using chemopreventive agents to enhance the efficacy of cancer therapy,” Cancer Research, vol. 66, no. 7, pp. 3347–3350, 2006. View at Publisher · View at Google Scholar · View at Scopus
14. F. H. Sarkar and Y. W. Li, “Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy,” Acta Pharmacologica Sinica, vol. 28, no. 9, pp. 1305–1315, 2007. View at Publisher · View at Google Scholar · View at Scopus
15. F. H. Sarkar, Y. Li, Z. Wang, and D. Kong, “Cellular signaling perturbation by natural products,” Cellular Signalling, vol. 21, no. 11, pp. 1541–1547, 2009. View at Publisher · View at Google Scholar · View at Scopus
16. F. H. Sarkar and Y. Li, “Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics,” Cancer Treatment Reviews, vol. 35, no. 7, pp. 597–607, 2009. View at Publisher · View at Google Scholar · View at Scopus
17. A. R. Evans, M. Limp-Foster, and M. R. Kelley, “Going APE over Ref-1,” Mutation Research, vol. 461, no. 2, pp. 83–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
18. M. L. Fishel and M. R. Kelley, “The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target,” Molecular Aspects of Medicine, vol. 28, no. 3-4, pp. 375–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
19. M. R. Kelley and M. L. Fishel, “DNA repair proteins as molecular targets for cancer therapeutics,” Anti-Cancer Agents in Medicinal Chemistry, vol. 8, no. 4, pp. 417–425, 2008. View at Publisher · View at Google Scholar · View at Scopus
20. A. Bapat, M. L. Fishel, and M. R. Kelley, “Going ape as an approach to cancer therapeutics,” Antioxidants & Redox Signaling, vol. 11, no. 3, pp. 651–667, 2009. View at Publisher · View at Google Scholar · View at Scopus
21. M. Luo, H. He, M. R. Kelley, and M. M. Georgiadis, “Redox regulation of DNA repair: implications for human health and cancer therapeutic development,” Antioxidants & Redox Signaling, vol. 12, no. 11, pp. 1247–1269, 2010. View at Publisher · View at Google Scholar · View at Scopus
22. W. G. Verly and Y. Paquette, “An endonuclease for depurinated DNA in Escherichia coli B,” Canadian Journal of Biochemistry, vol. 50, no. 2, pp. 217–224, 1972. View at Scopus
23. S. Ljungquist and T. Lindahl, “A mammalian endonuclease specific for apurinic sites in double-stranded deoxyribonucleic acid. I. Purification and general properties,” The Journal of Biological Chemistry, vol. 249, no. 5, pp. 1530–1535, 1974. View at Scopus
24. S. Ljungquist, A. Andersson, and T. Lindahl, “A mammalian endonuclease specific for apurinic sites in double-stranded deoxyribonucleic acid. II. Further studies on the substrate specificity,” The Journal of Biological Chemistry, vol. 249, no. 5, pp. 1536–1540, 1974. View at Scopus
25. S. C. Popoff, A. I. Spira, A. W. Johnson, and B. Demple, “Yeast structural gene (APN1) for the major apurinic endonuclease: homology to Escherichia coli endonuclease IV,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 11, pp. 4193–4197, 1990. View at Publisher · View at Google Scholar · View at Scopus
26. S. Seki, K. Akiyama, S. Watanabe, M. Hatsushika, S. Ikeda, and K. Tsutsui, “cDNA and deduced amino acid sequence of a mouse DNA repair enzyme (APEX nuclease) with significant homology to Escherichia coli exonuclease III,” The Journal of Biological Chemistry, vol. 266, no. 31, pp. 20797–20802, 1991. View at Scopus
27. S. Seki, S. Ikeda, S. Watanabe et al., “A mouse DNA repair enzyme (APEX nuclease) having exonuclease and apurinic/apyrimidinic endonuclease activities: purification and characterization,” Biochimica et Biophysica Acta, vol. 1079, no. 1, pp. 57–64, 1991. View at Publisher · View at Google Scholar · View at Scopus
28. C. N. Robson and I. D. Hickson, “Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E.Coli xth (exonuclease III) mutants,” Nucleic Acids Research, vol. 19, no. 20, pp. 5519–5523, 1991. View at Scopus
29. D. M. Wilson III, T. M. Sofinowski, and D. R. McNeill, “Repair mechanisms for oxidative DNA damage,” Frontiers in Bioscience, vol. 8, pp. d963–d981, 2003. View at Scopus
30. J. Nakamura, V. E. Walker, P. B. Upton, S.-Y. Chiang, Y. W. Kow, and J. A. Swenberg, “Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions,” Cancer Research, vol. 58, no. 2, pp. 222–225, 1998. View at Scopus
31. J. Nakamura and J. A. Swenberg, “Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues,” Cancer Research, vol. 59, no. 11, pp. 2522–2526, 1999. View at Scopus
32. R. M. Schaaper, T. A. Kunkel, and L. A. Loeb, “Infidelity of DNA synthesis associated with bypass of apurinic sites,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 2, pp. 487–491, 1983. View at Scopus
33. S.-L. Yu, S.-K. Lee, R. E. Johnson, L. Prakash, and S. Prakash, “The stalling of transcription at abasic sites is highly mutagenic,” Molecular and Cellular Biology, vol. 23, no. 1, pp. 382–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
34. A. M. Wilstermann and N. Osheroff, “Base excision repair intermediates as topoisomerase II poisons,” The Journal of Biological Chemistry, vol. 276, no. 49, pp. 46290–46296, 2001. View at Publisher · View at Google Scholar · View at Scopus
35. E. C. Friedberg, G. C. Walker, and W. Siede, DNA Repair and Mutagenesis, ASM Press, Washington, DC, USA, 2nd edition, 1995.
36. D. K. Srivastava, B. J. Vande Berg, R. Prasad et al., “Mammalian abasic site base excision repair: identification of the reaction sequence and rate-determining steps,” The Journal of Biological Chemistry, vol. 273, no. 33, pp. 21203–21209, 1998. View at Publisher · View at Google Scholar · View at Scopus
37. T. Izumi, T. K. Hazra, I. Boldogh et al., “Requirement for human AP endonuclease 1 for repair of $3^{\prime }$-blocking damage at DNA single-strand breaks induced by reactive oxygen species,” Carcinogenesis, vol. 21, no. 7, pp. 1329–1334, 2000. View at Scopus
38. B. Demple and M. S. DeMott, “Dynamics and diversions in base excision DNA repair of oxidized abasic lesions,” Oncogene, vol. 21, no. 58, pp. 8926–8934, 2002. View at Publisher · View at Google Scholar · View at Scopus
39. A. E. Tomkinson, L. Chen, Z. Dong et al., “Completion of base excision repair by mammalian DNA ligases,” Progress in Nucleic Acid Research and Molecular Biology, vol. 68, pp. 151–164, 2001. View at Scopus
40. S. Xanthoudakis and T. Curran, “Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity,” The EMBO Journal, vol. 11, no. 2, pp. 653–665, 1992. View at Scopus
41. S. Xanthoudakis, G. Miao, F. Wang, Y. C. E. Pan, and T. Curran, “Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme,” The EMBO Journal, vol. 11, no. 9, pp. 3323–3335, 1992. View at Scopus
42. M. Luo, J. Zhang, H. He, et al., “Characerization of the redox activity and disulfide bond formation in apurinic/apyrimidinic endonuclease,” Biochemistry, vol. 51, no. 2, pp. 696–705, 2012. View at Publisher · View at Google Scholar
43. L. B. Meira, S. Devaraj, G. E. Kisby et al., “Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress,” Cancer Research, vol. 61, no. 14, pp. 5552–5557, 2001. View at Scopus
44. D. L. Ludwig, M. A. MacInnes, Y. Takiguchi et al., “A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity,” Mutation Research, vol. 409, no. 1, pp. 17–29, 1998. View at Publisher · View at Google Scholar · View at Scopus
45. S. Xanthoudakis, R. J. Smeyne, J. D. Wallace, and T. Curran, “The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 17, pp. 8919–8923, 1996. View at Publisher · View at Google Scholar · View at Scopus
46. R. Abbotts and S. Madhusudan, “Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer,” Cancer Treatment Reviews, vol. 36, no. 5, pp. 425–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
47. D. C. Cabelof, J. J. Raffoul, S. Yanamadala, Z. Guo, and A. R. Heydari, “Induction of DNA polymerase β-dependent base excision repair in response to oxidative stress in vivo,” Carcinogenesis, vol. 23, no. 9, pp. 1419–1425, 2002. View at Scopus
48. A. Unnikrishnan, J. J. Raffoul, H. V. Patel et al., “Oxidative stress alters base excision repair pathway and increases apoptotic response in apurinic/apyrimidinic endonuclease 1/redox factor-1 haploinsufficient mice,” Free Radical Biology and Medicine, vol. 46, no. 11, pp. 1488–1499, 2009. View at Publisher · View at Google Scholar · View at Scopus
49. J. J. Raffoul, D. C. Cabelof, J. Nakamura, L. B. Meira, E. C. Friedberg, and A. R. Heydari, “Apurinic/apyrimidinic endonuclease (APE/REF-1) haploinsufficient mice display tissue-specific differences in DNA polymerase β-dependent base excision repair,” The Journal of Biological Chemistry, vol. 279, no. 18, pp. 18425–18433, 2004. View at Publisher · View at Google Scholar · View at Scopus
50. J. Huamani, C. A. McMahan, D. C. Herbert et al., “Spontaneous mutagenesis is enhanced in Apex heterozygous mice,” Molecular and Cellular Biology, vol. 24, no. 18, pp. 8145–8153, 2004. View at Publisher · View at Google Scholar · View at Scopus
51. L. B. Meira, S. Devaraj, G. E. Kisby et al., “Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress,” Cancer Research, vol. 61, no. 14, pp. 5552–5557, 2001. View at Scopus
52. S. Grösch, G. Fritz, and B. Kaina, “Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation,” Cancer Research, vol. 58, no. 19, pp. 4410–4416, 1998. View at Scopus
53. C. V. Ramana, I. Boldogh, T. Izumi, and S. Mitra, “Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5061–5066, 1998. View at Publisher · View at Google Scholar · View at Scopus
54. Y. Ono, T. Furuta, T. Ohmoto, K. Akiyama, and S. Seki, “Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease,” Mutation Research, vol. 315, no. 1, pp. 55–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
55. L. J. Walker, R. B. Craig, A. L. Harris, and I. D. Hickson, “A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress,” Nucleic Acids Research, vol. 22, no. 23, pp. 4884–4889, 1994. View at Scopus
56. H. Fung and B. Demple, “A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells,” Molecular Cell, vol. 17, no. 3, pp. 463–470, 2005. View at Publisher · View at Google Scholar · View at Scopus
57. T. Izumi, D. B. Brown, C. V. Naidu et al., “Two essential but distinct functions of the mammalian abasic endonuclease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5739–5743, 2005. View at Publisher · View at Google Scholar · View at Scopus
58. M. R. Vasko, C. Guo, and M. R. Kelley, “The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress,” DNA Repair, vol. 4, no. 3, pp. 367–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
59. J. J. Raffoul, S. Banerjee, V. Singh-Gupta et al., “Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo,” Cancer Research, vol. 67, no. 5, pp. 2141–2149, 2007. View at Publisher · View at Google Scholar · View at Scopus
60. V. Singh-Gupta, M. C. Joiner, L. Runyan et al., “Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer,” Journal of Thoracic Oncology, vol. 6, no. 4, pp. 688–698, 2011. View at Publisher · View at Google Scholar · View at Scopus
61. L. E. Huang, Z. Arany, D. M. Livingston, and H. F. Bunn, “Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit,” The Journal of Biological Chemistry, vol. 271, no. 50, pp. 32253–32259, 1996. View at Publisher · View at Google Scholar · View at Scopus
62. K. A. Robertson, H. A. Bullock, Y. Xu et al., “Altered expression of Ape1/Ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation,” Cancer Research, vol. 61, no. 5, pp. 2220–2225, 2001. View at Scopus
63. D. Wang, M. Luo, and M. R. Kelley, “Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition,” Molecular Cancer Therapeutics, vol. 3, no. 6, pp. 679–686, 2004. View at Scopus
64. S. H. Macphail, J. P. Banáth, T. Y. Yu, E. H. M. Chu, H. Lambur, and P. L. Olive, “Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays,” International Journal of Radiation Biology, vol. 79, no. 5, pp. 351–358, 2003. View at Publisher · View at Google Scholar · View at Scopus
65. L. Geng, K. C. Cuneo, A. Fu, T. Tu, P. W. Atadja, and D. E. Hallahan, “Histone deacetylase (HDAC) inhibitor LBH589 increases duration of γ-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer,” Cancer Research, vol. 66, no. 23, pp. 11298–11304, 2006. View at Publisher · View at Google Scholar · View at Scopus
66. V. Singh-Gupta, H. Zhang, S. Banerjee et al., “Radiation-induced HIF-1α cell survival pathway is inhibited by soy isoflavones in prostate cancer cells,” International Journal of Cancer, vol. 124, no. 7, pp. 1675–1684, 2009. View at Publisher · View at Google Scholar · View at Scopus
67. M. Jang, L. Cai, G. O. Udeani et al., “Cancer chemopreventive activity of resveratrol, a natural product derived from grapes,” Science, vol. 275, no. 5297, pp. 218–220, 1997. View at Scopus
68. S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal, “Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9,” Cancer Research, vol. 62, no. 17, pp. 4945–4954, 2002. View at Scopus
69. C. Gill, S. E. Walsh, C. Morrissey, J. M. Fitzpatrick, and R. W. G. Watson, “Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms,” Prostate, vol. 67, no. 15, pp. 1641–1653, 2007. View at Publisher · View at Google Scholar · View at Scopus
70. B. A. Narayanan, N. K. Narayanan, G. G. Re, and D. W. Nixon, “Differential expression of genes induced by resveratrol in LNCaP cells: p53-mediated molecular targets,” International Journal of Cancer, vol. 104, no. 2, pp. 204–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
71. M. H. Aziz, M. Nihal, V. X. Fu, D. F. Jarrard, and N. Ahmad, “Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol $3^{\prime }$-kinase/Akt pathway and Bcl-2 family protients,” Molecular Cancer Therapeutics, vol. 5, no. 5, pp. 1335–1341, 2006. View at Publisher · View at Google Scholar · View at Scopus
72. X. Ma, X. Tian, X. Huang, F. Yan, and D. Qiao, “Resveratrol-induced mitochondrial dysfunction and apoptosis are associated with Ca²⁺ and mCICR-mediated MPT activation in HepG2 cells,” Molecular and Cellular Biochemistry, vol. 302, no. 1-2, pp. 99–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
73. Z. J. Sun, C. E. Pan, H. S. Liu, and G. J. Wang, “Anti-hepatoma activity of resveratrol in vitro,” World Journal of Gastroenterology, vol. 8, no. 1, pp. 79–81, 2002. View at Scopus
74. N. Carbó, P. Costelli, F. M. Baccino, F. J. López-Soriano, and J. M. Argilés, “Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model,” Biochemical and Biophysical Research Communications, vol. 254, no. 3, pp. 739–743, 1999. View at Publisher · View at Google Scholar · View at Scopus
75. X. Z. Ding and T. E. Adrian, “Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells,” Pancreas, vol. 25, no. 4, pp. e71–e76, 2002. View at Scopus
76. T. Kubota, Y. Uemura, M. Kobayashi, and H. Taguchi, “Combined effects of resveratrol and paclitaxel on lung cancer cells,” Anticancer Research, vol. 23, no. 5, pp. 4039–4046, 2003. View at Scopus
77. S. L. Wu, Z. J. Sun, L. Yu, K. W. Meng, X. L. Qin, and C. E. Pan, “Effect of resveratrol and in combination with 5-FU on murine liver cancer,” World Journal of Gastroenterology, vol. 10, no. 20, pp. 3048–3052, 2004. View at Scopus
78. D. J. Boocock, G. E. Faust, K. R. Patel et al., “Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 6, pp. 1246–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
79. S. Yang, K. Irani, S. E. Heffron, F. Jurnak, and F. L. Meyskens Jr., “Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor,” Molecular Cancer Therapeutics, vol. 4, no. 12, pp. 1923–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
80. Y. J. Surh and K. S. Chun, “Cancer chemopreventive effects of curcumin,” Advances in Experimental Medicine and Biology, vol. 595, pp. 149–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
81. J. Y. Koo, H. J. Kim, K. O. Jung, and K. Y. Park, “Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil,” Journal of Medicinal Food, vol. 7, no. 2, pp. 117–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
82. A. B. Kunnumakkara, S. Guha, S. Krishnan, P. Diagaradjane, J. Gelovani, and B. B. Aggarwal, “Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products,” Cancer Research, vol. 67, no. 8, pp. 3853–3861, 2007. View at Publisher · View at Google Scholar · View at Scopus
83. S. Sen, H. Sharma, and N. Singh, “Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway,” Biochemical and Biophysical Research Communications, vol. 331, no. 4, pp. 1245–1252, 2005. View at Publisher · View at Google Scholar · View at Scopus
84. S. P. Verma, E. Salamone, and B. Goldin, “Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides,” Biochemical and Biophysical Research Communications, vol. 233, no. 3, pp. 692–696, 1997. View at Publisher · View at Google Scholar · View at Scopus
85. A. Khafif, S. P. Schantz, T. C. Chou, D. Edelstein, and P. G. Sacks, “Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells,” Carcinogenesis, vol. 19, no. 3, pp. 419–424, 1998. View at Publisher · View at Google Scholar · View at Scopus
86. A. L. Chen, C. H. Hsu, J. K. Lin et al., “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions,” Anticancer Research, vol. 21, no. 4, pp. 2895–2900, 2001. View at Scopus
87. A. B. Kunnumakkara, P. Anand, and B. B. Aggarwal, “Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins,” Cancer Letters, vol. 269, no. 2, pp. 199–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
88. C. V. Rao, A. Rivenson, B. Simi, and B. S. Reddy, “Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound,” Cancer Research, vol. 55, no. 2, pp. 259–266, 1995. View at Scopus
89. M. T. Huang, Y. R. Lou, W. Ma, H. L. Newmark, K. R. Reuhl, and A. H. Conney, “Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice,” Cancer Research, vol. 54, no. 22, pp. 5841–5847, 1994. View at Scopus
90. T. Kawamori, R. Lubet, V. E. Steele et al., “Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer,” Cancer Research, vol. 59, no. 3, pp. 597–601, 1999. View at Scopus
91. A. H. Conney, “Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture,” Cancer Research, vol. 63, no. 21, pp. 7005–7031, 2003. View at Scopus
92. N. Li, X. Chen, J. Liao et al., “Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin,” Carcinogenesis, vol. 23, no. 8, pp. 1307–1313, 2002. View at Scopus
93. M. Li, Z. Zhang, D. L. Hill, H. Wang, and R. Zhang, “Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway,” Cancer Research, vol. 67, no. 5, pp. 1988–1996, 2007. View at Publisher · View at Google Scholar · View at Scopus
94. G. Kuttan, K. B. Kumar, C. Guruvayoorappan, and R. Kuttan, “Antitumor, anti-invasion, and antimetastatic effects of curcumin,” Advances in Experimental Medicine and Biology, vol. 595, pp. 173–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
95. A. R. Bassiouny, A. Zaky, and K. M. Kandeel, “Alteration of AP-endonuclease 1 expression in curcumin-treated fibrotic rats,” Annals of Hepatology, vol. 10, no. 4, pp. 516–530, 2011.
96. Y. R. Seo, C. Sweeney, and M. L. Smith, “Selenomethionine induction of DNA repair response in human fibroblasts,” Oncogene, vol. 21, no. 23, pp. 3663–3669, 2002. View at Publisher · View at Google Scholar · View at Scopus
97. Y. R. Seo, M. R. Kelley, and M. L. Smith, “Selenomethionine regulation of p53 by a Ref1-dependent redox mechanism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 14548–14553, 2002. View at Publisher · View at Google Scholar · View at Scopus
98. E. C. Friedberg, G. C. Walker, and W. Siede, DNA Repair and Mutagenesis, ASM Press, Washington, DC, USA, 2nd edition, 1995.
99. A. R. Amin, O. Kucuk, F. R. Khuri, and D. M. Shin, “Perspectives for cancer prevention with natural compounds,” Journal of Clinical Oncology, vol. 27, no. 16, pp. 2712–2725, 2009. View at Publisher · View at Google Scholar · View at Scopus
100. I. U. Ahmad, J. D. Forman, F. H. Sarkar et al., “Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer,” Nutrition and Cancer, vol. 62, no. 7, pp. 996–1000, 2010. View at Publisher · View at Google Scholar · View at Scopus